3-[3-(2-fluorophenyl)-1,2,4-oxadiazol-5-yl]propanoic acid, 95.0%, 250mg

(2R,3R,5S,6S)-5,6-bis(azidomethyl)-2,3-dimethoxy-2,3-dimethyl 1,4 dioxane, 98.0%, 1g

N-(4-Benzyloxytrityl)-N'-(2-nitrobenzenesulfonyl)-1,3-diaminopropane Resin cross-linked with 1% DVB (200-400mesh) (0.9-1.1mmol/g)1g

(6-Methoxy-1H-indol-3-yl)methanamine, 95.0%, 5g

3,4-DIHYDRO-1,5-NAPHTHYRIDIN-2(1H)-ONE, 95.0%, 100mg

(6-Fluoropyridin-2-yl)methanamine dihydrochloride, 95.0%, 250mg

3-amino-4,5-dichlorobenzoic acid hydrochloride, 95.0%, 500mg

2-(3,4-Difluorophenyl)piperazine, 97.0%, 250mg

(S)-(-)-3-Amino-2-piperidone>98.0%(GC)1g

2,4,6-Trifluoropyridine, 95.0%, 10g

2-Propan-2-yladamantan-2-ol, 97%, 5g

7-(PHENYLSULFONYL)-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 10g

1-(4-Ethoxy-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid, 5g